Inactive Instrument

News Petlife Pharmaceuticals Inc Other OTC

Equities

US71639B1052

End-of-day quote Other OTC Other stock markets
- ^USD	-

2020	Petlife Pharmaceuticals, Inc. Announces Management Changes	CI
2018	Petlife Pharmaceuticals, Inc. Announces Management Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PETLIFE PHARMACEUTICALS, INC. : Other Events (form 8-K)	20-01-30	AQ
PETLIFE PHARMACEUTICALS, INC. : Completion of Acquisition or Disposition of Assets (form 8-K)	20-01-16	AQ
Petlife Pharmaceuticals, Inc. Announces Management Changes	20-01-16	CI
Petlife Pharmaceuticals, Inc. Announces Management Changes	18-06-06	CI
Petlife Pharmaceuticals, Inc. Announces Management Changes	18-03-28	CI
Petlife Pharmaceuticals, Inc. cancelled the transaction announced on June 22, 2016	17-06-21	CI
Petlife Pharmaceuticals, Inc. Announces Resignation of Geoffrey Broderick as President	17-04-17	CI
Petlife Pharmaceuticals, Inc. Appoints Geoffrey Broderick as President	17-02-03	CI
PetLife Pharmaceuticals, Inc. Announces Addition of Vyvyan Campbell to the Board of Directors	16-10-24	CI
PetLife Pharmaceuticals, Inc. Expands Cell Line Study with InnoVision Therapeutics in Preparation for FDA/CVM Registration Submission	16-10-13	CI
Petlife Pharmaceuticals, Inc. will Change its Ticker to PTLFD from PTLF	16-09-12	CI
PetLife Pharmaceuticals Announces Pre-INAD (Investigational New Animal Drug) Cell Lines Study of Vitalzul™	16-09-07	CI
PetLife Pharmaceuticals, Inc. Signs Contract with InnoVision Therapeutics	16-08-27	CI
Petlife Pharmaceuticals, Inc. Announces Management Appointments	16-07-25	CI
Petlife Pharmaceuticals, Inc. announced that it expects to receive $4 million in funding	16-06-21	CI
Petlife Pharmaceuticals, Inc. Appoints Ralph T. Salvagno to its Board of Directors and as the Chairman of the Board of Directors	16-03-25	CI
Petlife Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	16-01-05	CI
Petlife Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	15-12-30	CI
Petlife Pharmaceuticals, Inc. Appoints Sebastian Serrell-Watts as Executive Vice President and Secretary of the Company	14-10-03	CI
Petlife Pharmaceuticals, Inc. announced that it expects to receive $5 million in funding.	14-09-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Petlife Pharmaceuticals Inc Other OTC

Equities

US71639B1052

Summary

Filters